Jeonghun Seo

Dr. Jeonghun Seo

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
KCKi Hong Choi
Ki Hong Choi
JYJeong Hoon Yang
Jeong Hoon Yang
JSJeonghun Seo
Jeonghun Seo
DHDavid Hong
David Hong
TYTaeho Youn
Taeho Youn
EJEun‐Seok Jeon
Eun‐Seok Jeon
Background: Recently, diastolic stress testing and invasive hemodynamic measurements have been emphasized for diagnosis of heart failure with preserved ejection fraction (HFpEF) because when determined using noninvasive parameters it can fall into a nondiagnostic intermediate range. The current study evaluated the discriminative and prognostic roles of invasive measured left ventricular end‐diastolic pressure in the population with suspected HFpEF, particularly for patients with intermediate Heart Failure Association Pre‐test Assessment, Echocardiography & Natriuretic Peptide, Functional Testing, Final Etiology (HFA‐PEFF) score. Methods and Results: A total of 404 patients with symptoms or signs of HF and preserved left ventricular systolic function were enrolled. All subjects underwent left heart catheterization with left ventricular end‐diastolic pressure measurement for confirmation of HFpEF (≥16 mm Hg). The primary outcome was all‐cause death or readmission due to HF within 10 years. Among the study population, 324 patients (80.2%) were diagnosed as invasively confirmed HFpEF, and 80 patients (19.8%) were as noncardiac dyspnea. The patients with HFpEF showed a significantly higher HFA‐PEFF score than the patients with noncardiac dyspnea (3.8±1.8 versus 2.6±1.5, P <0.001). The discriminative ability of the HFA‐PEFF score for diagnosing HFpEF was modest (area under the curve, 0.70 [95% CI, 0.64–0.75], P <0.001). The HFA‐PEFF score was associated with a significantly higher 10‐year risk of death or HF readmission (per‐1 increase, hazard ratio [HR], 1.603 [95% CI, 1.376–1.868], P <0.001). Among the 226 patients with an intermediate HFA‐PEFF score (2–4), those with invasively confirmed HFpEF had a significantly higher risk of death or HF readmission within 10 years than the patients with noncardiac dyspnea (24.0% versus 6.9%, HR, 3.327 [95% CI, 1.109–16.280], P =0.030). Conclusions: The HFA‐PEFF score is a moderately useful tool for predicting future adverse events in suspected HFpEF, and invasively measured left ventricular end‐diastolic pressure can provide additional information to discriminate patient prognosis, particularly in those with intermediate HFA‐PEFF scores. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04505449.

8 September 2020 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
DKDong-Yeon Kim
Dong-Yeon Kim
SKSo Ree Kim
So Ree Kim
SPSung-Ji Park
Sung-Ji Park
JSJeonghun Seo
Jeonghun Seo
EKEun Kyoung Kim
Eun Kyoung Kim
SPSeung Woo Park
Seung Woo Park
Aims Although some peripartum‐associated cardiomyopathy patients present with features that are clinically and echocardiographically similar to those of takotsubo cardiomyopathy (TCM), little is known about the diagnosis and clinical course of peripartum TCM. Methods and results In a tertiary hospital in Seoul, Korea, we searched the hospital database to find cardiomyopathy cases that were associated with pregnancy from January 1995 to May 2019. Applying the published diagnostic criteria, we sought peripartum cardiomyopathy (PPCM) and peripartum TCM patients for comparison. Of 31 pregnancy‐associated cardiomyopathy patients, 10 cases of peripartum TCM and 21 cases of PPCM were found. Maternal near‐miss death was significantly more common in the peripartum TCM group than in the PPCM group (100.0% vs. 57.1%, P = 0.030). Complete recovery was observed with all peripartum TCM cases, while 23.8% of the PPCM cases had residual left ventricular dysfunction. One death and one heart transplantation occurred in the PPCM group, while neither occurred in the peripartum TCM group. There was no difference between the two groups in terms of the rate of major adverse clinical events at 3 years of follow‐up [PPCM group: 26.3% (5/19) vs. TCM group: 33.3% (3/9), P = 0.750]. Conclusions One‐third of pregnancy‐associated cardiomyopathy patients had peripartum TCM. With contemporary supportive care, both PPCM and peripartum TCM patients had a low mortality rate and excellent long‐term outcomes.

1 January 2023 in Journal of Cardiovascular Intervention
Verified
Journal Article
Open access
PDF file
BLBong-Ki Lee
Bong-Ki Lee
HSHye-Young Shin
Hye-Young Shin
KKKang Hee Kim
Kang Hee Kim
JSJeonghun Seo
Jeonghun Seo
KCKwang Jin Chun
Kwang Jin Chun
BCByung-ryul Cho
Byung-ryul Cho
Lee BK, et al. J Cardiovasc Interv. 2023 Apr;2:e20. https://doi.org/10.54912/jci.2023.0009

5 August 2022 in ESC Heart Failure
Verified
Journal Article
Open access
JSJeonghun Seo
Jeonghun Seo
IPIlkun Park
Ilkun Park
SPSung-Ji Park
Sung-Ji Park
DJDong Seop Jeong
Dong Seop Jeong
MBMinjung Bak
Minjung Bak
SPSeung Woo Park
Seung Woo Park
Aims: Tricuspid valve (TV) surgery for functional tricuspid regurgitation (TR) is becoming more common, but the associated mortality remains high. Therefore, we evaluated the clinical and echocardiographic parameters associated with all-cause mortality in patients with severe functional TR who underwent TV surgery. Methods and results: A total of 286 patients with severe functional TR who underwent TV replacement or repair was analysed between January 2006 and December 2017. We assessed changes in conventional echocardiographic parameters and strain, such as peak atrial longitudinal strain (PALS). During a median follow-up period of 5.3 years, 71 (24.8%) patients died due to any cause. When comparing groups with and without all-cause deaths, there were no significant differences in terms of sex, co-morbidities, medication use, and surgery type. However, patients who died were older and more likely to have refractory atrial fibrillation (AF). With multivariate Cox modelling, age >65 years (adjusted hazard ratio [HR], 2.81, 95% confidence interval [CI], 1.59–4.96; P < 0.001), refractory AF (adjusted HR, 2.84, 95% CI, 1.36–5.94; P = 0.006), lower albumin level (adjusted HR, 0.50, 95% CI, 0.31–0.82), and reduced PALS (adjusted HR, 1.87, 95% CI, 1.06–3.33; P = 0.032) were significant determinants of all-cause mortality. PALS decline was associated with refractory AF (adjusted HR, 5.74, 95% CI, 2.81–11.7; P < 0.001) and the absence of a Maze procedure (adjusted HR, 2.95, 95% CI, 1.51–5.78; P = 0.002). Conclusions: A reduction in PALS was significantly associated with all-cause mortality in our cohort of patients with severe functional TR who underwent TV surgery. This phenomenon is related to refractory AF and more aggressive intervention for AF is necessary concomitant with TV surgery.

9 May 2023 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
JSJeonghun Seo
Jeonghun Seo
KKKang Hee Kim
Kang Hee Kim
KCKwang Jin Chun
Kwang Jin Chun
BLBong-Ki Lee
Bong-Ki Lee
BCByung-Ryul Cho
Byung-Ryul Cho
DRDong Ryeol Ryu
Dong Ryeol Ryu
The pressure increase per time unit (dP/dt) in aortic stenosis (AS) jet velocity is assumed to have inter-individual variability in the progressive AS stage. We sought to examine the association of aortic valve (AoV) Doppler-derived dP/dt in patients with mild to moderate AS with risk of progression to severe disease. A total of 481 patients diagnosed with mild or moderate AS [peak aortic jet velocity (Vmax) between 2 and 4 m/s] according to echocardiographic criteria were included. AoV Doppler-derived dP/dt was determined by measuring the time needed for the pressure to increase at a velocity of the AoV jet from 1 m/s to 2 m/s. During a median follow-up period of 2.7 years, 12 of 404 (3%) patients progressed from mild to severe AS and 31 of 77 (40%) patients progressed from moderate to severe AS. AoV Doppler-derived dP/dt had a good ability to predict risk of progression to severe AS (area under the curve = 0.868) and the cut-off value was 600 mmHg/s. In multivariable logistic regression, initial AoV calcium score (adjusted odds ratio [aOR], 1.79; 95% confidence interval [CI], 1.18–2.73; P = 0.006) and AoV Doppler-derived dP/dt (aOR, 1.52/100 mmHg/s higher dP/dt; 95% CI, 1.10–2.05; P = 0.012) were associated with progression to severe AS. AoV Doppler-derived dP/dt above 600 mmHg/s was associated with risk of AS progression to the severe stage in patients with mild to moderate AS. This may be useful in individualized surveillance strategies for AS progression. Aortic valve Doppler-derived dP/dt above 600 mmHg/s has an ability to predict the risk of progression to severe aortic stenosis in patients with mild to moderate disease. AS, aortic stenosis; AoV, aortic valve.

23 October 2025 in BMJ Open
Verified
Journal Article
Open access
PDF file
HKHun-Tae Kim
Hun-Tae Kim
JSJeonghun Seo
Jeonghun Seo
JBJun Ho Bae
Jun Ho Bae
TKTae Jin Kim
Tae Jin Kim
YKYou Min Kim
You Min Kim
DHDong Sun Han
Dong Sun Han
Objectives To explore the association between the degree of coronary artery calcium (CAC) and the progression of calcific aortic valve disease (CAVD). Design A single-centre retrospective cohort study using a hospital-based database. Participants A total of 2898 patients who underwent coronary CT angiography and serial echocardiograms at ≥6 months apart were included. Initial echocardiography was performed within 6 months from the time of CCTA. Outcome measures CAC was divided into four groups: 0, 1–99, 100–399 and ≥400 (Agatston units, AU). The progression of CAVD was defined in two ways: progression 1 as at least one grade of progression, progression 2 as at least moderate aortic stenosis (AS) at follow-up. Results At the initial CAVD grade, patients with at least mild AS tended to increase with increasing CAC (p<0.001). During a median follow-up of 3.2 years (IQR, 1.8–5.0 years), 101 patients (3.5%) experienced progression 1 and 24 patients (0.8%) suffered progression 2. There was a statistically significant increase in risk of progression 1 in CAC 100–399 and ≥400 groups than CAC 0 and 1–99 groups (p<0.001). In progression 2, the CAC≥400 group showed a higher progression rate than the other groups (p<0.001). In multivariable logistic regression, age (adjusted OR (aOR), 1.06; 95% CI, 1.02 to 1.09; p=0.001), CAC≥400 (aOR, 2.55 vs CAC 0 as a reference group; 95% CI, 1.19 to 5.46; p=0.016), body mass index (aOR, 1.09; 95% CI, 1.02 to 1.17; p=0.010) and initial peak aortic jet velocity (aOR, 1.21 per 0.1 m/s increase; 95% CI, 1.14 to 1.28; p<0.001) were associated with progression 1. In progression 2, CAC≥400 (aOR, 44.5 vs CAC 0 as a reference group; 95% CI, 1.09 to 1810; p=0.045), eGFR (aOR, 0.88; 95% CI, 0.80 to 0.97; p=0.007), left ventricular mass index (aOR, 1.05; 95% CI, 1.01 to 1.10; p=0.029) and initial peak aortic jet velocity (aOR, 4.21 per 0.1 m/s increase; 95% CI, 1.86 to 9.53; p=0.001) were significant determinants. Conclusions CAC was significantly associated with the progression of CAVD. Particularly, CAC≥400 was linked to progression toward significant AS.